Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to reveal how different forms of milk casein, lactose and moderate breakdown of proteins affect the symptoms that may arise from milk and markers of inflammation in volunteers receiving symptoms from milk. Research hypotheses are: 1) Protein hydrolyzed milk is as tolerated or better tolerated than A2 milk, and 2) Lactose is the main causative agent of stomach symptoms in milk-sensitive individuals.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05305391
Study type Interventional
Source University of Turku
Contact
Status Completed
Phase N/A
Start date May 18, 2022
Completion date March 3, 2023

See also
  Status Clinical Trial Phase
Completed NCT03060395 - Effects of A2 Milk on Gastrointestinal Function in Non-lactose Milk Intolerance N/A